Recent Advances in Colorectal Cancer Screening
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: 1 December 2024 | Viewed by 1211
Special Issue Editors
2. RICAPPS (Research Network on Chronicity, Primary Care and Health Promotion), Madrid, Spain
Interests: epidemiology; colorectal cancer; screening and prevention; screening personalization; barriers and facilitators to screening; ethics in public health
2. Ciber Salud Pública (CIBERESP), Instituto Salud Carlos III, Madrid, Spain
Interests: colorectal cancer; screening; quality indicators; adverse effects; barriers and facilitators to adherence
Special Issue Information
Dear Colleagues,
Colorectal cancer screening is nowadays widely carried out as an opportunistic intervention or as a population-based program. Although its efficacy is well documented, there are still many unanswered questions and challenges ahead. Coverage and uptake rates are below acceptable standards in many regions, with significant inequities being described. Personalized screening has gathered much attention in the last few years; however, despite substantial evidence that it may greatly benefit patients and reduce the disease burden, which strategy or combination of strategies is the most effective is still unknown. The fecal immunochemical test (FIT), sigmoidoscopy and colonoscopy are the most widely used screening and diagnostic tests, but more advanced and newer technologies are being proposed either as complementary or alternative tests in some settings. Biomarkers are one of these promising new technologies, although evidence of their effectiveness in real settings is still lacking.
This Special Issue aims to further advance the field of colorectal cancer screening via 1) increasing uptake and coverage rates; 2) reducing inequalities; 3) describing and tackling communication issues, enhancing informed participation; 4) proposing personalized screening strategies; 5) highlighting new screening and diagnostic tools. This Special Issue welcomes both original research articles and reviews.
Dr. Andrea Burón
Dr. Gemma Binefa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- colorectal cancer
- screening
- fecal immunochemical test
- colonoscopy
- personalization strategies
- cancer inequalities
- quality indicators
- decision aids
